Education
About Us
Working with TipRanks
Follow Us
Xylo Technologies Ltd (XYLO)
NASDAQ:XYLO
Top Page
Xylo Technologies Ltd
(NASDAQ:XYLO)
53Neutral
Xylo Technologies Ltd (XYLO) vs. S&P 500 (SPY)
Market Cap
$3.67M
Dividend YieldN/A
Average Volume (3M)14.22K
Price to Earnings (P/E)―
Beta (1Y)0.26
Revenue Growth-47.53%
EPS Growth0.67%
CountryUS
Employees84
SectorHealthcare
Sector Strength72
IndustryMedical - Devices
Share Statistics
EPS (TTM)-23.59
Shares Outstanding747,332
10 Day Avg. Volume15,479
30 Day Avg. Volume14,216
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.04
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Xylo Technologies Ltd Business Overview & Revenue Model
Company DescriptionXylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
How the Company Makes Money
Xylo Technologies Ltd Financial Statement Overview
Summary
Overall, Xylo Technologies Ltd is grappling with significant financial challenges across its income statement, balance sheet, and cash flow. The company struggles with profitability, despite revenue growth, and faces cash flow issues that could impact its ability to sustain operations. While its debt position is not critically high, declining equity and persistent losses pose long-term financial risks.Income Statement
Xylo Technologies Ltd has faced significant challenges in maintaining profitability, as indicated by its negative EBIT and net income over multiple years. Although revenue has increased substantially since 2019, gross profit margins remain low or negative, suggesting cost control issues. The lack of positive revenue growth in the most recent year compounds these concerns.28
Negative
Balance Sheet
The balance sheet shows a moderate level of financial stability with a debt-to-equity ratio that is manageable, supported by a relatively higher equity ratio. However, the decline in stockholders' equity over recent years highlights potential vulnerabilities. While the company's total liabilities have increased over the years, the debt levels are not excessively high, which provides some comfort.55
Neutral
Cash Flow
The cash flow statement reveals persistent negative operating cash flow and free cash flow, indicating financial strain. The company's ability to convert operating profits into cash is weak, as evidenced by negative free cash flow to net income ratios. The growth of free cash flow is also negative, highlighting ongoing challenges in cash generation.40
Negative
| Breakdown | |||||
| TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 57.64M | 91.72M | 91.86M | 10.12M | 531.00K | 273.00K | Gross Profit |
| 7.80M | 11.84M | 14.45M | 4.80M | -503.00K | -182.00K | EBIT |
| -17.94M | -23.32M | -8.58M | -8.20M | -7.46M | -4.20M | EBITDA |
| -5.20M | -16.30M | -5.38M | 6.99M | -7.30M | -13.89M | Net Income Common Stockholders |
| -15.99M | -16.02M | -9.81M | 6.79M | -4.33M | -14.18M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 25.23M | 12.54M | 25.23M | 27.34M | 22.36M | 7.04M | Total Assets |
| 97.65M | 63.90M | 97.65M | 59.73M | 32.34M | 13.33M | Total Debt |
| 10.13M | 9.79M | 10.13M | 1.62M | 107.00K | 152.00K | Net Debt |
| -10.12M | 429.00K | -10.12M | -22.41M | -22.26M | -6.88M | Total Liabilities |
| 42.96M | 31.46M | 42.96M | 8.30M | 6.14M | 5.20M | Stockholders Equity |
| 39.14M | 23.58M | 39.14M | 49.19M | 22.96M | 6.71M |
| Cash Flow | Free Cash Flow | ||||
| -4.15M | -7.99M | -5.73M | -10.39M | -6.47M | -2.76M | Operating Cash Flow |
| -4.11M | -6.25M | -5.66M | -5.25M | -6.14M | -2.69M | Investing Cash Flow |
| 2.73M | -4.06M | -4.48M | -12.21M | -1.60M | -917.00K | Financing Cash Flow |
| -4.27M | -524.00K | 5.41M | 18.92M | 22.95M | -46.00K |
Xylo Technologies Ltd Technical Analysis
Positive
4.91
Price Trends
4.66
Positive
4.15
Positive
4.06
Positive
Market Momentum
0.13
Positive
54.35
Neutral
37.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XYLO, the sentiment is Positive. The current price of 4.91 is below the 20-day moving average (MA) of 5.00, above the 50-day MA of 4.66, and above the 200-day MA of 4.06, indicating a neutral trend. The MACD of 0.13 indicates Positive momentum. The RSI at 54.35 is Neutral, neither overbought nor oversold. The STOCH value of 37.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XYLO.
Xylo Technologies Ltd Risk Analysis
Xylo Technologies Ltd disclosed 79 risk factors in its most recent earnings report. Xylo Technologies Ltd reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Xylo Technologies Ltd Peers Comparison
Overall Rating
UnderperformOutperform
Sector (48)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $195.35B | 25.75 | 27.26% | 1.77% | 4.10% | 9.78% | |
75 Outperform | $76.34B | 22.86 | 33.16% | 2.27% | 3.08% | 11.92% | |
72 Outperform | $37.84B | 16.97 | 16.21% | 1.58% | 1.98% | 7.16% | |
68 Neutral | $32.09B | 28.29 | 16.59% | 2.01% | -3.41% | 67.87% | |
53 Neutral | $3.67M | ― | -68.97% | ― | -47.53% | 0.67% | |
48 Neutral | $6.84B | 1.02 | -53.11% | 2.50% | 16.84% | 0.92% | |
47 Neutral | $3.09B | 267.98 | -2.46% | ― | -5.65% | 78.20% |
* Healthcare Sector Average
Performance Comparison
XYLO
Xylo Technologies Ltd
4.91
-2.51
-33.83%
ACN
Accenture
313.58
-17.36
-5.25%
CTSH
Cognizant
76.45
5.88
8.33%
INFY
Infosys
18.20
1.10
6.43%
WIT
Wipro
3.06
0.30
10.87%
DXC
DXC Technology
17.34
-3.72
-17.66%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.